LEMBOREXANT vs LENALIDOMIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LEMBOREXANT vs LENALIDOMIDE: Safety Overview
| Metric | LEMBOREXANT | LENALIDOMIDE |
|---|---|---|
| Total FAERS Reports | 989 | 349,955 |
| Deaths Reported | 44 | 35,942 |
| Death Rate | 4.4% | 10.3% |
| Hospitalizations | 278 | 86,495 |
| Average Patient Age | 58.9 yrs | 69.9 yrs |
| % Female Patients | 63.4% | 50.0% |
| FDA Approval Date | Apr 7, 2020 | Aug 3, 2023 |
| Manufacturer | Eisai Inc. | Padagis US LLC |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |